|
|
Peplin, Incorporation - Comparative Business Analysis Snapshot
Business Description
Peplin, Incorporation. The Group's principal activities are developing and commercializing medical dermatology products for the treatment of cancers and other diseases . Its products include PEP005 Topical gel, which is used for treating Actinic keratosis (AK) and Basal cell carcinoma (BCC), PEP005 IV for Leukemia, PEP005 IC for Superficial bladder cancer and EPUFAs for general cancer and pain. It operates in Australia.
Competitor Analysis
This analysis compares Peplin, Incorporation with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
